NO922224L - Fremgangsmaate og anvendelse av a-c-b-proinsulin - Google Patents

Fremgangsmaate og anvendelse av a-c-b-proinsulin

Info

Publication number
NO922224L
NO922224L NO92922224A NO922224A NO922224L NO 922224 L NO922224 L NO 922224L NO 92922224 A NO92922224 A NO 92922224A NO 922224 A NO922224 A NO 922224A NO 922224 L NO922224 L NO 922224L
Authority
NO
Norway
Prior art keywords
insulin
molecules
provides
compounds
species
Prior art date
Application number
NO92922224A
Other languages
English (en)
Norwegian (no)
Other versions
NO922224D0 (no
Inventor
Rama M Belagaje
Richard Dennis Dimarchi
Jr William Francis Heath
Harlan Beall Long
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO922224D0 publication Critical patent/NO922224D0/no
Publication of NO922224L publication Critical patent/NO922224L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO92922224A 1991-06-11 1992-06-05 Fremgangsmaate og anvendelse av a-c-b-proinsulin NO922224L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/715,183 US5304473A (en) 1991-06-11 1991-06-11 A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production

Publications (2)

Publication Number Publication Date
NO922224D0 NO922224D0 (no) 1992-06-05
NO922224L true NO922224L (no) 1992-12-14

Family

ID=24872995

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922224A NO922224L (no) 1991-06-11 1992-06-05 Fremgangsmaate og anvendelse av a-c-b-proinsulin

Country Status (23)

Country Link
US (1) US5304473A (ja)
EP (1) EP0518587B1 (ja)
JP (1) JPH05255392A (ja)
KR (1) KR930000536A (ja)
CN (1) CN1068501A (ja)
AT (1) ATE166106T1 (ja)
AU (1) AU648670B2 (ja)
BR (1) BR9202180A (ja)
CA (1) CA2070503C (ja)
CZ (1) CZ171492A3 (ja)
DE (1) DE69225432T2 (ja)
DK (1) DK0518587T3 (ja)
ES (1) ES2116315T3 (ja)
FI (1) FI922645A (ja)
HU (1) HUT63193A (ja)
IE (1) IE921862A1 (ja)
IL (1) IL102107A0 (ja)
MX (1) MX9202726A (ja)
NO (1) NO922224L (ja)
NZ (1) NZ243089A (ja)
SK (1) SK171492A3 (ja)
YU (1) YU59392A (ja)
ZA (1) ZA924080B (ja)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378613A (en) * 1991-09-24 1995-01-03 Eli Lilly And Company Method for increased expression of low molecular weight recombinant polypeptides
US6348327B1 (en) * 1991-12-06 2002-02-19 Genentech, Inc. Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
ATE241012T1 (de) * 1993-06-21 2003-06-15 Genentech Inc Verfahren zur herstellung von humanen relaxin
US5646242A (en) 1994-11-17 1997-07-08 Eli Lilly And Company Selective acylation of epsilon-amino groups
US5665591A (en) * 1994-12-06 1997-09-09 Trustees Of Boston University Regulation of smooth muscle cell proliferation
KR0150565B1 (ko) * 1995-02-15 1998-08-17 김정재 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
US5576197A (en) * 1995-04-07 1996-11-19 Molecular Bio-Products Polymerase chain reaction container and methods of using the same
CA2223272A1 (en) * 1995-05-05 1996-11-07 Ronald Eugene Chance Single chain insulin with high bioactivity
US5631347A (en) * 1995-06-07 1997-05-20 Eli Lilly And Company Reducing gelation of a fatty acid-acylated protein
US5700904A (en) * 1995-06-07 1997-12-23 Eli Lilly And Company Preparation of an acylated protein powder
GB9513967D0 (en) * 1995-07-08 1995-09-06 Univ Leicester Insulin
US5905140A (en) * 1996-07-11 1999-05-18 Novo Nordisk A/S, Novo Alle Selective acylation method
US7169889B1 (en) 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US7378390B2 (en) * 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US6926898B2 (en) * 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
US7790690B2 (en) 2000-10-11 2010-09-07 U.S. Department Of Veterans Affairs Glucose sensitive regulator of insulin transcription
WO2002051428A1 (fr) * 2000-12-25 2002-07-04 Shiseido Company, Ltd. Composition de parfum stimulant le systeme sympathique
US6867183B2 (en) * 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US7105314B2 (en) * 2001-04-02 2006-09-12 Novo Nordisk A/S Method for making human insulin precursors
CA2446739A1 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
US6828305B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7196059B2 (en) * 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7166571B2 (en) * 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6913903B2 (en) * 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
EP1463752A4 (en) * 2001-12-21 2005-07-13 Human Genome Sciences Inc ALBUMIN FUSION PROTEINS
ES2500918T3 (es) * 2001-12-21 2014-10-01 Human Genome Sciences, Inc. Proteínas de fusión de albúmina e interferón beta
WO2003105768A2 (en) * 2002-06-13 2003-12-24 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
US20050026826A1 (en) * 2003-01-17 2005-02-03 Margarethe Hoenig Feline proinsulin, insulin and constituent peptides
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
JP5697831B2 (ja) 2003-12-03 2015-04-08 ノヴォ ノルディスク アー／エス 単鎖インシュリン
CN105801686B (zh) 2004-07-19 2020-04-07 比奥孔有限公司 胰岛素-低聚物共轭物、制剂及其用途
US20090099095A1 (en) * 2007-05-16 2009-04-16 Peter Eriksson Novel neuroprotective peptide
EP2203181B1 (en) * 2007-10-16 2018-02-14 Biocon Limited An orally administerable solid pharmaceutical composition and a process thereof
CN103930440A (zh) * 2011-07-01 2014-07-16 拜耳知识产权有限责任公司 松弛素融合多肽及其用途
CA2890048C (en) 2012-12-03 2022-05-03 Merck Sharp & Dohme Corp. O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
AU2014329567B2 (en) 2013-10-04 2019-07-25 Merck Sharp & Dohme Corp. Glucose-responsive insulin conjugates
AU2015349890B2 (en) 2014-11-21 2018-08-30 Merck Sharp & Dohme Llc Insulin receptor partial agonists
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
WO2017189342A1 (en) 2016-04-26 2017-11-02 Merck Sharp & Dohme Corp. Insulin dimer-incretin conjugates
WO2017205191A1 (en) 2016-05-24 2017-11-30 Merck Sharp & Dohme Corp. Insulin receptor partial agonists and glp-1 analogues
US10689430B2 (en) 2016-05-25 2020-06-23 Merck Sharp & Dohme Corp. Insulin receptor partial agonists
CA3030642A1 (en) 2016-07-18 2018-01-25 Eth Zurich B-cell-mimetic cells
EP3272877A1 (en) 2016-07-18 2018-01-24 ETH Zurich B-cell-mimetic cells
US11230585B2 (en) 2016-09-06 2022-01-25 Chemical & Biopharmaceutical Laboratories Of Patra Proinsulin derivatives
WO2018175272A1 (en) 2017-03-23 2018-09-27 Merck Sharp & Dohme Corp. Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666884A (en) * 1984-04-10 1987-05-19 New England Deaconess Hospital Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls
AU641631B2 (en) * 1988-12-23 1993-09-30 Novo Nordisk A/S Human insulin analogues
PT93057B (pt) * 1989-02-09 1995-12-29 Lilly Co Eli Processo para a preparacao de analogos da insulina
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser

Also Published As

Publication number Publication date
US5304473A (en) 1994-04-19
YU59392A (sh) 1994-11-15
IE921862A1 (en) 1992-12-16
FI922645A (fi) 1992-12-12
BR9202180A (pt) 1993-02-02
ES2116315T3 (es) 1998-07-16
CN1068501A (zh) 1993-02-03
NZ243089A (en) 1994-01-26
AU1806992A (en) 1993-03-11
EP0518587A2 (en) 1992-12-16
HU9201915D0 (en) 1992-08-28
KR930000536A (ko) 1993-01-15
DE69225432T2 (de) 1998-10-01
IL102107A0 (en) 1993-01-14
SK171492A3 (en) 1995-04-12
CA2070503A1 (en) 1992-12-12
DK0518587T3 (da) 1998-10-19
HUT63193A (en) 1993-07-28
NO922224D0 (no) 1992-06-05
JPH05255392A (ja) 1993-10-05
MX9202726A (es) 1992-12-01
CA2070503C (en) 1999-01-12
CZ171492A3 (en) 1993-05-12
FI922645A0 (fi) 1992-06-08
ATE166106T1 (de) 1998-05-15
DE69225432D1 (de) 1998-06-18
EP0518587A3 (en) 1993-12-01
AU648670B2 (en) 1994-04-28
EP0518587B1 (en) 1998-05-13
ZA924080B (en) 1993-12-06

Similar Documents

Publication Publication Date Title
NO922224D0 (no) Fremgangsmaate og anvendelse av a-c-b-proinsulin
EP0464022A4 (en) Insulinotropic hormone
DK1105460T3 (da) Differentiering af ikke-insulinproducerende celler til insulinproducerende celler med GLP-1 eller Exendin-4 og anvendelser deraf
DE69027666D1 (de) Herstellung von biologischaktivem insulinähnlichem wachstumsfaktor i aus hochexpressions-wirtszellsystemen
IL101686A (en) Process for increasing the in vivo yield of native protein when disulfide-bonded proteins are secreted
EP0271824A3 (en) Horse gamma interferon
HUT46546A (en) Process for production of crystall-mixtures containing insuline or derivatives of insuline and medical preparatives containing such crystalls
NO843109L (no) Fremgagsmaate til fremstilling av insulinderivater
IE810709L (en) Chiral hydantoins
HK1042113A1 (zh) 從新的融合蛋白製備重組胰島素的方法
AU7542187A (en) Light inducible promoter
DK1291429T3 (da) Glutamin-fruktose-6-fosfat-amidotransferase-splice-variant og dets ekspressionsprodukt
AU643773B2 (en) Growth hormone releasing factor analogs
ATE152127T1 (de) Muteine des menschlichen parathormons und ihre herstellung
HU9401821D0 (en) Ureins derived from alpha, omega-diamino-acids and process for producing them
DK0487229T3 (da) DNA, der koder for et protein, som binder til enhanceren for alfa-føtoproteingenet
DE68919619D1 (de) DNA-Sequenz, beteiligt an der Regulation der Expression einer DNA-Sequenz, die einen Polypeptid-Precursor kodiert, Expressionsvektoren und Methode der periplasmatischen Herstellung des Polypeptides.